Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-05 00:35 | 2021-08-02 | AAT | American Assets Trust, Inc. | RADY ERNEST S | Director, Officer, 10% owner - Chairman & CEO | Real Estate Investment Trusts | BUY | $36.76 | 29,623 | $1,088,873 | 6,301,793 | +0.5% |
| 2021-08-05 04:17 | 2021-08-02 | RLYB | Rallybio Corp | 5AM Opportunities I, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $13.00 | 615,384 | $7,999,992 | 1,406,098 | +77.8% |
| 2021-08-04 23:05 | 2021-08-02 | VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Director | Pharmaceutical Preparations | BUY | $197.91 | 15,000 | $2,968,650 | 41,210 | +57.2% |
| 2021-08-04 13:05 | 2021-08-03 | IMRX | Immuneering Corp | CARPENTER ROBERT J | Director | Pharmaceutical Preparations | BUY | $15.00 | 325,000 | $4,875,000 | 1,148,839 | +39.4% |
| 2021-08-05 01:16 | 2021-08-02 | CFX | Enovis CORP | RALES MITCHELL P | Director | Orthopedic, Prosthetic & Surgical Appliances & Supplies | BUY | $46.19 | 250,200 | $11,555,987 | 1,170,201 | +27.2% |
| 2021-08-04 03:17 | 2021-07-30 | DALS | N/A | DA32 Sponsor LLC | 10% owner | Other | BUY | $10.00 | 650,000 | $6,500,000 | 650,000 | +100.0% |
| 2021-08-04 03:55 | 2021-07-30 | MEAC | N/A | Garrou Marshall Blair | Director, 10% owner | Other | BUY | $10.00 | 875,000 | $8,750,000 | 875,000 | +100.0% |
| 2021-08-04 00:59 | 2021-07-30 | RANI | Rani Therapeutics Holdings, Inc. | Quiroga Moreno Isidoro | 10% owner | Pharmaceutical Preparations | BUY | $11.01 | 6,458,904 | $71,087,989 | 11,731,654 | +122.5% |
| 2021-08-04 04:47 | 2021-07-30 | DALS | N/A | Section 32 Fund 3, LP | Director, 10% owner, Other | Other | BUY | $10.00 | 800,000 | $8,000,000 | 800,000 | +100.0% |
| 2021-08-03 23:51 | 2021-08-03 | INAB | IN8BIO, INC. | FAIRBAIRN EMILY | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 100,000 | $1,000,000 | 3,322,485 | +3.1% |
| 2021-08-04 01:56 | 2021-08-02 | ICVX | N/A | Gould Terry P | Director | Other | BUY | $15.00 | 133,334 | $2,000,010 | 256,783 | +108.0% |
| 2021-08-04 01:08 | 2021-07-30 | MXCT | MAXCYTE, INC. | Casdin Partners Master Fund, L.P. | 10% owner | Services-Commercial Physical & Biological Research | BUY | $13.00 | 1,800,000 | $23,400,000 | 13,971,334 | +14.8% |
| 2021-08-04 04:06 | 2021-07-30 | DALS | N/A | ARCH Venture Fund XI, L.P. | 10% owner | Other | BUY | $10.00 | 1,600,000 | $16,000,000 | 1,600,000 | +100.0% |
| 2021-08-04 04:12 | 2021-07-30 | DALS | N/A | CRANDELL KEITH | Director, 10% owner | Other | BUY | $10.00 | 1,600,000 | $16,000,000 | 1,600,000 | +100.0% |
| 2021-08-04 02:45 | 2021-07-30 | ALZN | Alzamend Neuro Inc. | AULT MILTON C III | 10% owner | Pharmaceutical Preparations | BUY | $1.52 | 1,340,333 | $2,031,811 | 6,681,888 | +25.1% |
| 2021-08-04 01:24 | 2021-08-02 | ICVX | N/A | ADAMS STREET PARTNERS LLC | Other | Other | BUY | $15.00 | 133,334 | $2,000,010 | 256,783 | +108.0% |
| 2021-08-04 00:16 | 2021-07-30 | OMGA | N/A | Invus Public Equities, L.P. | 10% owner | Other | BUY | $16.93 | 950,000 | $16,085,305 | 2,273,530 | +71.8% |
| 2021-08-04 03:27 | 2021-07-30 | DALS | N/A | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Director, 10% owner, Other | Other | BUY | $10.00 | 1,600,000 | $16,000,000 | 1,600,000 | +100.0% |
| 2021-08-03 00:24 | 2021-08-02 | IMAQ | International Media Acquisition Corp. | Content Creation Media LLC | 10% owner | Services-Motion Picture & Video Tape Production | BUY | $10.00 | 714,400 | $7,144,000 | 6,314,400 | +12.8% |
| 2021-08-03 00:23 | 2021-08-02 | IMAQ | International Media Acquisition Corp. | Sarkar Shibasish | Director, Officer, 10% owner - Chief Executive Officer | Services-Motion Picture & Video Tape Production | BUY | $10.00 | 714,400 | $7,144,000 | 6,314,400 | +12.8% |
| 2021-08-03 03:12 | 2021-07-29 | CADL | Candel Therapeutics, Inc. | Martell Christopher | Director | Biological Products, (No Diagnostic Substances) | BUY | $8.00 | 125,000 | $1,000,000 | 125,000 | +100.0% |
| 2021-08-02 20:48 | 2021-07-30 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $21.52 | 232,336 | $5,000,003 | 38,240,405 | +0.6% |
| 2021-08-02 19:58 | 2021-07-30 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $21.52 | 697,007 | $15,000,010 | 10,915,301 | +6.8% |
| 2021-08-02 19:58 | 2021-07-30 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $21.52 | 1,045,511 | $22,500,016 | 27,735,749 | +3.9% |
| 2021-08-03 04:55 | 2021-07-29 | IEA | N/A | ARES MANAGEMENT LLC | Director, 10% owner | Other | BUY | $11.00 | 3,185,039 | $35,035,429 | 3,185,039 | +100.0% |
| 2021-08-03 04:27 | 2021-08-02 | ICVX | N/A | Qiming U.S. Healthcare Fund II, L.P. | Other | Other | BUY | $15.00 | 221,351 | $3,320,265 | 3,523,561 | +6.7% |
| 2021-08-03 04:56 | 2021-07-29 | IEA | N/A | Ares Management Corp | Director, 10% owner | Other | BUY | $11.00 | 3,185,039 | $35,035,429 | 3,185,039 | +100.0% |
| 2021-08-03 03:34 | 2021-08-02 | ICVX | N/A | Sanofi | 10% owner | Other | BUY | $15.00 | 66,667 | $1,000,005 | 3,155,169 | +2.2% |
| 2021-08-03 03:40 | 2021-07-29 | RLYB | Rallybio Corp | VIKING GLOBAL INVESTORS LP | 10% owner | Pharmaceutical Preparations | BUY | $13.00 | 806,000 | $10,478,000 | 4,194,777 | +23.8% |
| 2021-08-03 00:07 | 2021-07-26 | WHLM | Wilhelmina International, Inc. | Retail Ecommerce Ventures LLC | 10% owner | Services-Management Consulting Services | BUY | $10.00 | 237,500 | $2,375,000 | 475,000 | +100.0% |
| 2021-07-30 22:27 | 2021-07-29 | GIM | Saba Capital Income & Opportunities Fund II | Saba Capital Management, L.P. | 10% owner | Other | BUY | $5.57 | 450,000 | $2,506,500 | 27,956,781 | +1.6% |
| 2021-07-31 01:37 | 2021-07-28 | CRCT | Cricut, Inc. | Abdiel Capital Management, LLC | 10% owner | Special Industry Machinery, NEC | BUY | $33.79 | 804,109 | $27,167,868 | 5,019,606 | +19.1% |
| 2021-07-30 23:25 | 2021-07-28 | HOOD | Robinhood Markets, Inc. | RUBINSTEIN JONATHAN | Director | Security Brokers, Dealers & Flotation Companies | BUY | $38.00 | 52,631 | $1,999,978 | 52,631 | +100.0% |
| 2021-07-31 01:00 | 2021-07-30 | BECN | N/A | CD&R Investment Associates IX, Ltd. | 10% owner | Other | BUY | $55.53 | 108,056 | $5,999,971 | 14,429,028 | +0.8% |
| 2021-07-29 19:37 | 2021-05-03 | N-A | N/A | Fisk Darren | Director, Officer - Chief Executive Officer | Other | BUY | $10.00 | 3,146,611 | $31,466,113 | 126,828 | +100.0% |
| 2021-07-29 23:30 | 2021-07-27 | CTKB | Cytek Biosciences, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Laboratory Analytical Instruments | BUY | $17.00 | 2,950,000 | $50,150,000 | 1,185,767 | +100.0% |
| 2021-07-30 00:38 | 2021-07-27 | N-A | Copper Property CTL Pass Through Trust | Silver Point Capital L.P. | 10% owner | Real Estate | BUY | $19.00 | 119,915 | $2,278,385 | 13,782,439 | +0.9% |
| 2021-07-28 15:50 | 2021-07-16 | IMRA | Enliven Therapeutics, Inc. | Chin Mark | Director | Pharmaceutical Preparations | BUY | $6.00 | 1,333,333 | $7,999,998 | 2,344,072 | +131.9% |
| 2021-07-28 23:30 | 2021-07-26 | ABSI | Absci Corporation | Casdin Eli | Director | Services-Commercial Physical & Biological Research | BUY | $16.00 | 1,562,500 | $25,000,000 | 6,745,333 | +30.1% |
| 2021-07-28 23:33 | 2021-07-26 | ABSI | Absci Corporation | Casdin Partners Master Fund, L.P. | Director | Services-Commercial Physical & Biological Research | BUY | $16.00 | 1,562,500 | $25,000,000 | 6,745,333 | +30.1% |
| 2021-07-28 23:49 | 2021-07-26 | FST | N/A | Chatham Asset Management, LLC | 10% owner | Other | BUY | $12.21 | 202,500 | $2,473,457 | 3,574,862 | +6.0% |
| 2021-07-29 00:24 | 2019-07-23 | RZLT | Rezolute, Inc. | Genexine Inc. | 10% owner | Pharmaceutical Preparations | BUY | $0.29 | 34,482,758 | $10,000,000 | 91,300,933 | +60.7% |
| 2021-07-29 04:01 | 2021-07-26 | ABSI | Absci Corporation | Redmile Group, LLC | Director | Services-Commercial Physical & Biological Research | BUY | $16.00 | 1,875,000 | $30,000,000 | 8,031,094 | +30.5% |
| 2021-07-28 18:55 | 2021-07-26 | N/A | N/A | Golub Lawrence E | Director, Officer - Chairman | Other | BUY | $15.00 | 76,702 | $1,150,525 | 1,057,925 | +7.8% |
| 2021-07-28 18:54 | 2021-07-26 | N/A | N/A | Golub David | Director, Officer - President and CEO | Other | BUY | $15.00 | 76,702 | $1,150,525 | 1,057,925 | +7.8% |
| 2021-07-28 19:23 | 2021-07-26 | MTEM | N/A | BIOTECH TARGET N V | 10% owner | Other | BUY | $7.04 | 155,000 | $1,091,650 | 9,942,003 | +1.6% |
| 2021-07-28 23:56 | 2021-07-26 | CCI | CROWN CASTLE INC. | MARTIN J LANDIS | Director | Real Estate Investment Trusts | BUY | $191.51 | 11,200 | $2,144,857 | 14,700 | +320.0% |
| 2021-07-28 23:31 | 2021-07-26 | RYAN | RYAN SPECIALTY HOLDINGS, INC. | MCKENNA ANDREW J | Director | Insurance Agents, Brokers & Service | BUY | $23.50 | 120,000 | $2,820,000 | 120,000 | +100.0% |
| 2021-07-28 23:30 | 2021-07-26 | RYAN | RYAN SPECIALTY HOLDINGS, INC. | OHALLERAN MICHAEL D | Director | Insurance Agents, Brokers & Service | BUY | $23.50 | 199,000 | $4,676,500 | 218,383 | +1,026.7% |
| 2021-07-28 03:58 | 2021-07-23 | KLTR | KALTURA INC | .406 Ventures I GP, LLC | 10% owner | Services-Prepackaged Software | BUY | $10.00 | 200,000 | $2,000,000 | 200,000 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.